OVID - Ovid Therapeutics Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development33,790.03149,972.1029,585.6496,611.948
Selling General and Administrative19,141.65215,035.46112,949.5256,578.426
Non Recurring----
Others----
Total Operating Expenses52,931.68365,007.56322,535.17413,190.374
Operating Income or Loss-52,931.683-65,007.563-22,535.174-13,190.374
Income from Continuing Operations
Total Other Income/Expenses Net952.073201.509120.82230.281
Earnings Before Interest and Taxes-52,931.683-65,007.563-22,535.174-13,190.374
Interest Expense----
Income Before Tax-51,979.61-64,806.054-22,414.352-13,160.093
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-51,979.61-64,806.054-22,414.352-13,160.093
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-51,979.61-64,806.054-22,414.352-13,160.093
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-51,979.61-64,806.054-22,414.352-13,160.093